Cargando…
ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer
Prostate cancer is the most frequently diagnosed cancer and the fifth leading cause of cancer death among men in 2020. The clinical decision making for prostate cancer patients is based on the stratification of the patients according to both clinical and pathological parameters such as Gleason score...
Autores principales: | Montanaro, Manuela, Agostini, Massimiliano, Anemona, Lucia, Bonanno, Elena, Servadei, Francesca, Finazzi Agrò, Enrico, Asimakopoulos, Anastasios D., Ganini, Carlo, Cipriani, Chiara, Signoretti, Marta, Bove, Pierluigi, Rugolo, Francesco, Imperiali, Benedetta, Melino, Gerry, Mauriello, Alessandro, Scimeca, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095592/ https://www.ncbi.nlm.nih.gov/pubmed/37047491 http://dx.doi.org/10.3390/ijms24076519 |
Ejemplares similares
-
The ZNF750–RAC1 axis as potential prognostic factor for breast cancer
por: Butera, Alessio, et al.
Publicado: (2020) -
The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis
por: Scimeca, Manuel, et al.
Publicado: (2022) -
No Time to Die: How Kidney Cancer Evades Cell Death
por: Ganini, Carlo, et al.
Publicado: (2022) -
Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End‐Stage Renal Disease
por: Mauriello, Alessandro, et al.
Publicado: (2015) -
The Paradox Effect of Calcification in Carotid Atherosclerosis: Microcalcification Is Correlated with Plaque Instability
por: Montanaro, Manuela, et al.
Publicado: (2021)